Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology
Search results for: physical function
What Diet to Recommend to Patients with Rheumatoid Arthritis?
With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis
EULAR 2013: Researchers Expand Targets for PsA, OA Therapy
Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis
RA Treatment Options Expanded with New Infusible TNF Inhibitor
FDA approves second infusible anti–tumor necrosis factor treatment for patients with moderate to severe rheumatoid arthritis. (posted Aug. 16, 2013)
Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis
Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities
Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?
Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)
ACR/ARHP Annual Meeting 2012: Physicians Search for Ways to Improve Clinical Outcomes for Total Knee Replacements (TKR)
Widely variable results for people post-TKR procedures have prompted doctors to develop a standardized approach to rehabilitation care
ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis
Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront
Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights
Rheumatology Drug Updates
Information on new approvals and medication safety rheumatologists need to know
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 80
- Next Page »